The level of FCGBP antigen in the serum of patients with ulcerative colitis and Crohn’s disease reflects the pathophysiologic state and can be used as a diagnostic marker for these autoimmune diseases (40). This evidence concerns the gene FCGBP and ulcerative colitis.